bourva
OMX · CPH Health Care NOVO-B

Novo Nordisk dividend history

NOVO-B · Novo Nordisk
DKK 420.00 ▼ DKK 2.92 · -0.69%
Market open · 15:26 local Jun 26, 2026 Prices delayed ≥15 min Sample data

Price chart

Key statistics

Market cap
DKK 1.83T
P/E (TTM)
19.0×
EPS (TTM)
DKK 22.11
Dividend yield
2.85%
52-week range
DKK 332.49 – DKK 460.19
Avg volume
12.1M
Beta
0.87
Prev close
DKK 422.92

About Novo Nordisk

AI-assisted summary

Novo Nordisk (NOVO-B) is a company listed on OMX in the Health Care sector. This page summarises its share price, key statistics, dividends and fundamentals using delayed and sample data — figures may differ from official sources.

Dividend history

Annual payout (TTM): DKK 11.99 · Forward yield: 2.85%
Ex-date Pay date Amount Frequency Dividend yield
Jun 21, 2026 Jun 28, 2026 DKK 5.99 Semi-annual 2.85%
Dec 20, 2025 Dec 27, 2025 DKK 6.00 Semi-annual 2.86%
Jun 20, 2025 Jun 27, 2025 DKK 6.11 Semi-annual 2.91%
Dec 19, 2024 Dec 26, 2024 DKK 5.82 Semi-annual 2.77%

Financials

Annual figures, last 5 fiscal years.

Date Revenue Net income EPS (TTM) P/E (TTM)
FY2024 DKK 865.03B DKK 176.72B DKK 17.57 18.9×
FY2023 DKK 784.21B DKK 86.67B DKK 19.27 23.2×
FY2022 DKK 667.61B DKK 96.28B DKK 20.35 19.1×
FY2021 DKK 624.04B DKK 101.08B DKK 22.54 21.5×
FY2020 DKK 529.97B DKK 77.19B DKK 24.53 24.3×

Stock splits

No stock splits on record for Novo Nordisk.

Analyst forecast

12-month price target
DKK 425.51
Consensus rating
Hold
Implied upside
+1.31%
Based on 16 analysts
12-month

Aggregated analyst estimates (sample)

Related

Frequently asked questions

What is the current Novo Nordisk share price?

Novo Nordisk (NOVO-B) last traded at DKK 420.00, as of Jun 26, 2026. Prices on bourva are delayed and shown for reference only.

Does Novo Nordisk pay a dividend?

Yes — Novo Nordisk has a forward dividend yield of about 2.85%, based on its trailing 12-month payout.

What is Novo Nordisk's market capitalisation?

Novo Nordisk has an approximate market capitalisation of DKK 1.83T.

What is Novo Nordisk's P/E ratio?

Novo Nordisk trades at a trailing P/E ratio of about 19.0.

Compare with another ticker
See two tickers side by side — price, valuation and dividends.